Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Saxonov Serge, holds the title of Chief Executive Officer at 10x Genomics, Inc..
On 2026-11-10, the insider transacted 31,000 shares.The shares were transacted at a weighted average price of $62.90 per share, resulting in a total market-relevant value of $1.9M.
Saxonov Serge (Chief Executive Officer) sold $1.9M of $TXG
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.